DKK3 and cancer: Since REIC/Dkk-3 expression is significantly downregulated in a broad range of human cancer cells, while being typically expressed in non-malignant or normal cells (9–17,22), the endogenous expression level of these proteins appear to correlate with sensitivity to the REIC/Dkk-3 overexpression induced by Ad-REIC.